Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation

International Journal of Antimicrobial Agents

Volumn 32, Issue 2, 2008, Pages 154-157

  Barberán, José ^a   Aguilar, Lorenzo ^b   Giménez, María José ^b   Carroquino, Guillermo ^a   Granizo, Juan Jose ^c   Prieto, José ^b  

^a HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

^c Grana Datos SL   (Spain)

Author keywords

Coagulase negative staphylococci; Implants; Internal fixation plates; Staphylococcus aureus

Indexed keywords

C REACTIVE PROTEIN; LEVOFLOXACIN; RIFAMPICIN;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMBINATION CHEMOTHERAPY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEBRIDEMENT; DEVICE INFECTION; DEVICE REMOVAL; FEMALE; FEMUR FRACTURE; FOLLOW UP; HUMAN; HUMERUS FRACTURE; IMPLANT; MALE; NONHUMAN; OSTEOSYNTHESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SPINE FRACTURE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYMPTOMATOLOGY; TIBIA FRACTURE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COAGULASE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; ORTHOPEDIC FIXATION DEVICES; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 46049083555     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.03.003     Document Type: Article

References (14)

1. Harris L.G., and Richards R.G. Staphylococci and implant surfaces: a review. Injury 37 Suppl. 2 (2006) S3-S14
2. Petty W., Spanier S., Shuster J.J., and Silverthorne C. The influence of skeletal implants on incidence of infection. Experiments in a canine model. J Bone Joint Surg Am 67 (1985) 1236-1244
3. Zimmerli W., Widmer A.F., Blatter M., Frei R., and Ochsner P.E. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279 (1998) 1537-1541
4. Gustilo R.B., Merkow R.L., and Templeman D. The management of open fractures. J Bone Joint Surg Am 72 (1990) 299-304
5. Donlan R.M. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33 (2001) 1387-1392
6. Dellamonica P., Etesse-Carsenti H., Bernard E., Mondain V., Durant J., and Argenson C. Pefloxacin in the treatment of bone infections associated with foreign material. J Antimicrob Chemother 26 Suppl. B (1990) 199-205
7. Gómez J., Rodríguez M., Baños V., Martínez L., Claver M.A., Ruiz J., et al. Orthopedic implant infection: prognostic factors and influence of long-term antibiotic treatment on evolution. Prospective study, 1992-1999. Enferm Infecc Microbiol Clin 21 (2003) 232-236 [in Spanish]
8. Barberán J., Aguilar L., Carroquino G., Gimenez M.J., Sanchez B., Martinez D., et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 119 (2006) e7-e10
9. Drancourt M., Stein A., Argenson J.N., Zannier A., Curvale G., and Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 37 (1993) 1214-1218
10. Bernard L., Hoffmeyer P., Assal M., Vaudaux P., Schrenzel J., and Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 53 (2004) 127-129
11. Widmer A.F., Gaechter A., Ochsner P.E., and Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 14 (1992) 1251-1253
12. Rimmele T., Boselli E., Breilh D., Djabarouti S., Bel J.C., Guyot R., et al. Diffusion of levofloxacin into bone and synovial tissues. J Antimicrob Chemother 53 (2004) 533-535
13. Stein A., Bataille J.F., Drancourt M., Curvale G., Argenson J.N., Groulier P., et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 42 (1998) 3086-3091
14. Lentino J.R. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis 36 (2003) 1157-1161